Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
901.2 INR | -0.70% | +3.81% | +18.65% |
06-18 | Alembic Pharmaceuticals Gets US FDA Nod for Dabigatran Etexilate Capsules | MT |
06-17 | Alembic Pharmaceuticals Gets US FDA's Final Approval for Generic Drug Angioedema | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.65% | 2.14B | |
+55.19% | 815B | |
+45.97% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+19.74% | 247B | |
+3.68% | 229B | |
+14.17% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- APLLTD Stock
- News Alembic Pharmaceuticals Limited
- Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit